Regeneron settles patent lawsuit over protein for testing COVID-19 treatments - Reuters

Reuters | Dec. 16, 2024, 4:48 p.m. | Original
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments Reuters
Exclusive: Brazilian investor Tanure in initial talks with Casino over GPA shares, says source - Reuters US stocks end higher ahead of Fed, bitcoin surges - Reuters